ID   EIF3I_HUMAN             Reviewed;         325 AA.
AC   Q13347;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 201.
DE   RecName: Full=Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008};
DE            Short=eIF3i {ECO:0000255|HAMAP-Rule:MF_03008};
DE   AltName: Full=Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008};
DE   AltName: Full=TGF-beta receptor-interacting protein 1;
DE            Short=TRIP-1;
DE   AltName: Full=eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008};
DE   AltName: Full=eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008};
GN   Name=EIF3I {ECO:0000255|HAMAP-Rule:MF_03008};
GN   Synonyms=EIF3S2 {ECO:0000255|HAMAP-Rule:MF_03008}, TRIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8995409; DOI=10.1074/jbc.272.28.17668;
RA   Asano K., Kinzy T.G., Merrick W.C., Hershey J.W.B.;
RT   "Conservation and diversity of eukaryotic translation initiation factor
RT   eIF3.";
RL   J. Biol. Chem. 272:1101-1109(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7566156; DOI=10.1038/377548a0;
RA   Chen R.H., Miettinen P.J., Maruka E.M., Choy L., Derynck R.;
RT   "A WD-domain protein that is associated with and phosphorylated by the type
RT   II TGF-beta receptor.";
RL   Nature 377:548-552(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 269-280 AND 283-298, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH EIF3B.
RX   PubMed=14519125; DOI=10.1046/j.1432-1033.2003.03807.x;
RA   Mayeur G.L., Fraser C.S., Peiretti F., Block K.L., Hershey J.W.B.;
RT   "Characterization of eIF3k: a newly discovered subunit of mammalian
RT   translation initiation factor eIF3.";
RL   Eur. J. Biochem. 270:4133-4139(2003).
RN   [6]
RP   INTERACTION WITH EIF3B.
RX   PubMed=14688252; DOI=10.1074/jbc.m312745200;
RA   Fraser C.S., Lee J.Y., Mayeur G.L., Bushell M., Doudna J.A.,
RA   Hershey J.W.B.;
RT   "The j-subunit of human translation initiation factor eIF3 is required for
RT   the stable binding of eIF3 and its subcomplexes to 40 S ribosomal subunits
RT   in vitro.";
RL   J. Biol. Chem. 279:8946-8956(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-308, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=15703437; DOI=10.1261/rna.7215305;
RA   Kolupaeva V.G., Unbehaun A., Lomakin I.B., Hellen C.U.T., Pestova T.V.;
RT   "Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits and
RT   its role in ribosomal dissociation and anti-association.";
RL   RNA 11:470-486(2005).
RN   [9]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16766523; DOI=10.1074/jbc.m605418200;
RA   LeFebvre A.K., Korneeva N.L., Trutschl M., Cvek U., Duzan R.D.,
RA   Bradley C.A., Hershey J.W.B., Rhoads R.E.;
RT   "Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e
RT   subunit.";
RL   J. Biol. Chem. 281:22917-22932(2006).
RN   [10]
RP   FUNCTION, AND CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=17581632; DOI=10.1038/sj.emboj.7601765;
RA   Masutani M., Sonenberg N., Yokoyama S., Imataka H.;
RT   "Reconstitution reveals the functional core of mammalian eIF3.";
RL   EMBO J. 26:3373-3383(2007).
RN   [11]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3 COMPLEX,
RP   AND MASS SPECTROMETRY.
RX   PubMed=17322308; DOI=10.1074/mcp.m600399-mcp200;
RA   Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V., Leary J.A.;
RT   "Structural characterization of the human eukaryotic initiation factor 3
RT   protein complex by mass spectrometry.";
RL   Mol. Cell. Proteomics 6:1135-1146(2007).
RN   [12]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3 COMPLEX,
RP   AND MASS SPECTROMETRY.
RX   PubMed=18599441; DOI=10.1073/pnas.0801313105;
RA   Zhou M., Sandercock A.M., Fraser C.S., Ridlova G., Stephens E.,
RA   Schenauer M.R., Yokoi-Fong T., Barsky D., Leary J.A., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V.;
RT   "Mass spectrometry reveals modularity and a complete subunit interaction
RT   map of the eukaryotic translation factor eIF3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18139-18144(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-264, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-219, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   FUNCTION, AND IDENTIFICATION IN THE EIF-3 COMPLEX.
RX   PubMed=25849773; DOI=10.1038/nature14267;
RA   Lee A.S., Kranzusch P.J., Cate J.H.;
RT   "eIF3 targets cell-proliferation messenger RNAs for translational
RT   activation or repression.";
RL   Nature 522:111-114(2015).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   FUNCTION.
RX   PubMed=27462815; DOI=10.1038/nature18954;
RA   Lee A.S., Kranzusch P.J., Doudna J.A., Cate J.H.;
RT   "eIF3d is an mRNA cap-binding protein that is required for specialized
RT   translation initiation.";
RL   Nature 536:96-99(2016).
RN   [19]
RP   3D-STRUCTURE MODELING, AND ELECTRON MICROSCOPY.
RX   PubMed=16322461; DOI=10.1126/science.1118977;
RA   Siridechadilok B., Fraser C.S., Hall R.J., Doudna J.A., Nogales E.;
RT   "Structural roles for human translation factor eIF3 in initiation of
RT   protein synthesis.";
RL   Science 310:1513-1515(2005).
CC   -!- FUNCTION: Component of the eukaryotic translation initiation factor 3
CC       (eIF-3) complex, which is required for several steps in the initiation
CC       of protein synthesis (PubMed:17581632, PubMed:25849773,
CC       PubMed:27462815). The eIF-3 complex associates with the 40S ribosome
CC       and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-
CC       tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The
CC       eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning
CC       of the mRNA for AUG recognition. The eIF-3 complex is also required for
CC       disassembly and recycling of post-termination ribosomal complexes and
CC       subsequently prevents premature joining of the 40S and 60S ribosomal
CC       subunits prior to initiation (PubMed:17581632). The eIF-3 complex
CC       specifically targets and initiates translation of a subset of mRNAs
CC       involved in cell proliferation, including cell cycling, differentiation
CC       and apoptosis, and uses different modes of RNA stem-loop binding to
CC       exert either translational activation or repression (PubMed:25849773).
CC       {ECO:0000255|HAMAP-Rule:MF_03008, ECO:0000269|PubMed:17581632,
CC       ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.
CC   -!- SUBUNIT: Component of the eukaryotic translation initiation factor 3
CC       (eIF-3) complex, which is composed of 13 subunits: EIF3A, EIF3B, EIF3C,
CC       EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J, EIF3K, EIF3L and
CC       EIF3M. The eIF-3 complex appears to include 3 stable modules: module A
CC       is composed of EIF3A, EIF3B, EIF3G and EIF3I; module B is composed of
CC       EIF3F, EIF3H, and EIF3M; and module C is composed of EIF3C, EIF3D,
CC       EIF3E, EIF3K and EIF3L. EIF3C of module C binds EIF3B of module A and
CC       EIF3H of module B, thereby linking the three modules. EIF3J is a labile
CC       subunit that binds to the eIF-3 complex via EIF3B. The eIF-3 complex
CC       interacts with RPS6KB1 under conditions of nutrient depletion.
CC       Mitogenic stimulation leads to binding and activation of a complex
CC       composed of MTOR and RPTOR, leading to phosphorylation and release of
CC       RPS6KB1 and binding of EIF4B to eIF-3. {ECO:0000255|HAMAP-
CC       Rule:MF_03008, ECO:0000269|PubMed:14519125,
CC       ECO:0000269|PubMed:14688252, ECO:0000269|PubMed:16766523,
CC       ECO:0000269|PubMed:17322308, ECO:0000269|PubMed:18599441,
CC       ECO:0000269|PubMed:25849773}.
CC   -!- INTERACTION:
CC       Q13347; P55212: CASP6; NbExp=3; IntAct=EBI-354047, EBI-718729;
CC       Q13347; Q6UXB4: CLEC4G; NbExp=3; IntAct=EBI-354047, EBI-2114729;
CC       Q13347; P55884: EIF3B; NbExp=7; IntAct=EBI-354047, EBI-366696;
CC       Q13347; O75821: EIF3G; NbExp=3; IntAct=EBI-354047, EBI-366632;
CC       Q13347; P42858: HTT; NbExp=13; IntAct=EBI-354047, EBI-466029;
CC       Q13347; P13473-2: LAMP2; NbExp=3; IntAct=EBI-354047, EBI-21591415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03008}.
CC   -!- PTM: Phosphorylated by TGF-beta type II receptor. {ECO:0000255|HAMAP-
CC       Rule:MF_03008}.
CC   -!- MASS SPECTROMETRY: Mass=36501.9; Method=Unknown;
CC       Evidence={ECO:0000269|PubMed:17322308};
CC   -!- MASS SPECTROMETRY: Mass=36503.2; Mass_error=0.4; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:18599441};
CC   -!- SIMILARITY: Belongs to the eIF-3 subunit I family. {ECO:0000255|HAMAP-
CC       Rule:MF_03008}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U39067; AAC97144.1; -; mRNA.
DR   EMBL; U36764; AAC50224.1; -; mRNA.
DR   EMBL; BC000413; AAH00413.1; -; mRNA.
DR   EMBL; BC003140; AAH03140.1; -; mRNA.
DR   CCDS; CCDS357.1; -.
DR   PIR; S60335; S60335.
DR   RefSeq; NP_003748.1; NM_003757.3.
DR   PDB; 6YBT; EM; 6.00 A; 2=1-325.
DR   PDB; 6ZMW; EM; 3.70 A; 2=1-325.
DR   PDB; 6ZON; EM; 3.00 A; I=1-325.
DR   PDB; 6ZP4; EM; 2.90 A; I=1-325.
DR   PDB; 6ZVJ; EM; 3.80 A; I=1-316.
DR   PDB; 7A09; EM; 3.50 A; I=1-325.
DR   PDBsum; 6YBT; -.
DR   PDBsum; 6ZMW; -.
DR   PDBsum; 6ZON; -.
DR   PDBsum; 6ZP4; -.
DR   PDBsum; 6ZVJ; -.
DR   PDBsum; 7A09; -.
DR   SMR; Q13347; -.
DR   BioGRID; 114217; 152.
DR   ComplexPortal; CPX-6036; Eukaryotic translation initiation factor 3 complex.
DR   CORUM; Q13347; -.
DR   DIP; DIP-31116N; -.
DR   IntAct; Q13347; 81.
DR   MINT; Q13347; -.
DR   STRING; 9606.ENSP00000362688; -.
DR   ChEMBL; CHEMBL4295814; -.
DR   iPTMnet; Q13347; -.
DR   MetOSite; Q13347; -.
DR   PhosphoSitePlus; Q13347; -.
DR   SwissPalm; Q13347; -.
DR   BioMuta; EIF3I; -.
DR   DMDM; 2494895; -.
DR   DOSAC-COBS-2DPAGE; Q13347; -.
DR   OGP; Q13347; -.
DR   EPD; Q13347; -.
DR   jPOST; Q13347; -.
DR   MassIVE; Q13347; -.
DR   PaxDb; Q13347; -.
DR   PeptideAtlas; Q13347; -.
DR   PRIDE; Q13347; -.
DR   ProteomicsDB; 59333; -.
DR   Antibodypedia; 31260; 171 antibodies.
DR   DNASU; 8668; -.
DR   Ensembl; ENST00000676801; ENSP00000503348; ENSG00000084623.
DR   Ensembl; ENST00000677202; ENSP00000504034; ENSG00000084623.
DR   Ensembl; ENST00000677701; ENSP00000503539; ENSG00000084623.
DR   Ensembl; ENST00000677711; ENSP00000504061; ENSG00000084623.
DR   Ensembl; ENST00000677760; ENSP00000502867; ENSG00000084623.
DR   GeneID; 8668; -.
DR   KEGG; hsa:8668; -.
DR   CTD; 8668; -.
DR   DisGeNET; 8668; -.
DR   GeneCards; EIF3I; -.
DR   HGNC; HGNC:3272; EIF3I.
DR   HPA; ENSG00000084623; Low tissue specificity.
DR   MIM; 603911; gene.
DR   neXtProt; NX_Q13347; -.
DR   OpenTargets; ENSG00000084623; -.
DR   PharmGKB; PA162384875; -.
DR   VEuPathDB; HostDB:ENSG00000084623.11; -.
DR   eggNOG; KOG0643; Eukaryota.
DR   GeneTree; ENSGT00940000167369; -.
DR   HOGENOM; CLU_043845_0_0_1; -.
DR   InParanoid; Q13347; -.
DR   OMA; VWFSHNG; -.
DR   OrthoDB; 866359at2759; -.
DR   PhylomeDB; Q13347; -.
DR   TreeFam; TF101515; -.
DR   PathwayCommons; Q13347; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   SignaLink; Q13347; -.
DR   SIGNOR; Q13347; -.
DR   BioGRID-ORCS; 8668; 795 hits in 972 CRISPR screens.
DR   ChiTaRS; EIF3I; human.
DR   GeneWiki; EIF3I; -.
DR   GenomeRNAi; 8668; -.
DR   Pharos; Q13347; Tbio.
DR   PRO; PR:Q13347; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q13347; protein.
DR   Bgee; ENSG00000084623; Expressed in left adrenal gland and 244 other tissues.
DR   ExpressionAtlas; Q13347; baseline and differential.
DR   Genevisible; Q13347; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016282; C:eukaryotic 43S preinitiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0033290; C:eukaryotic 48S preinitiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005852; C:eukaryotic translation initiation factor 3 complex; IDA:UniProtKB.
DR   GO; GO:0071541; C:eukaryotic translation initiation factor 3 complex, eIF3m; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0003743; F:translation initiation factor activity; IDA:UniProtKB.
DR   GO; GO:0002183; P:cytoplasmic translational initiation; IBA:GO_Central.
DR   GO; GO:0001732; P:formation of cytoplasmic translation initiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0006413; P:translational initiation; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   HAMAP; MF_03008; eIF3i; 1.
DR   InterPro; IPR027525; eIF3i.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM00320; WD40; 5.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Initiation factor; Isopeptide bond; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome; Repeat; Ubl conjugation; WD repeat.
FT   CHAIN           1..325
FT                   /note="Eukaryotic translation initiation factor 3 subunit
FT                   I"
FT                   /id="PRO_0000051036"
FT   REPEAT          1..39
FT                   /note="WD 1"
FT   REPEAT          43..81
FT                   /note="WD 2"
FT   REPEAT          87..127
FT                   /note="WD 3"
FT   REPEAT          135..175
FT                   /note="WD 4"
FT   REPEAT          180..217
FT                   /note="WD 5"
FT   REPEAT          221..267
FT                   /note="WD 6"
FT   REPEAT          275..316
FT                   /note="WD 7"
FT   MOD_RES         219
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         264
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         308
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   CROSSLNK        282
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
SQ   SEQUENCE   325 AA;  36502 MW;  02797BB72A752A96 CRC64;
     MKPILLQGHE RSITQIKYNR EGDLLFTVAK DPIVNVWYSV NGERLGTYMG HTGAVWCVDA
     DWDTKHVLTG SADNSCRLWD CETGKQLALL KTNSAVRTCG FDFGGNIIMF STDKQMGYQC
     FVSFFDLRDP SQIDNNEPYM KIPCNDSKIT SAVWGPLGEC IIAGHESGEL NQYSAKSGEV
     LVNVKEHSRQ INDIQLSRDM TMFVTASKDN TAKLFDSTTL EHQKTFRTER PVNSAALSPN
     YDHVVLGGGQ EAMDVTTTST RIGKFEARFF HLAFEEEFGR VKGHFGPINS VAFHPDGKSY
     SSGGEDGYVR IHYFDPQYFE FEFEA
//
